European Union has designated Cannabidiol (CBD) as Novel Food. Novel Foods are not allowed to be placed on the market without authorization. In 2019 a German court’s ruling classified CBD as either a prescription medicine or Novel Food. The Finnish Food Authority has recently issued a recall of extracts containing cannabinoids, such as CBD-A. The availability of products containing CBD in the EU market is changing.
